WHO ICTRP trial
Investigation of AllergyCut therapeutic effect of Allergic Rhinitis patients
IRCT20170705034915N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20170705034915N2 |
|---|---|
| Public title | Investigation of AllergyCut therapeutic effect of Allergic Rhinitis patients |
| Scientific title | Investigation of Effectiveness of AllergyCut on Reducing the Severity and intensity of Disease in Allergic Rhinitis Patients |
| Primary sponsor | MIM Daroo Pharmaceutical Co. |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Rhinitis Allergy. Allergic rhinitis, unspecified |
| Interventions | Intervention 1: Intervention group: Patients with allergic rhinitis: Use of AllergyCut contains distilled plant product intended to remove symptoms of allergic rhinitis for 120 days with permissible dose every 6 hours 1 puff per nasal… |
| Registration date | Feb 6, 2019 |
| Target size | 75 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: